Kentucky Products Liability: Senate votes to double attack on risky drugs
Senate votes to double attack on risky drugs
By Ricardo Alonso-Zaldivar
Los Angeles Times
WASHINGTON -- The Senate overwhelmingly approved a landmark drug-safety bill Wednesday that would double the number of government scientists assigned to ferret out risky side effects in medicines already on the market.
The bill also would create a computerized network to scan medical-insurance and pharmacy records for signs of trouble with new drugs and expand the Food and Drug Administration's (FDA) power to require drug makers to reduce risks.
"This is unquestionably the biggest change in the FDA's regulatory authority in a very long time," former FDA Commissioner Mark McClellan said.
This is great news for consumers across the country. For too long, drug companies have been pushing dangerous drugs through the FDA process. Kudos to the Senate.